02 July 2004
Candida albicans switch phenotpes display differential levels of fitness
Kaaren G. Vargas, Rupasree Srikantha, Anamika Holke, Tamim Sifri, Ryan Morris, Sophie JolyMed Sci Monit 2004; 10(7): BR198-206 :: ID: 11716
Abstract
Background:Candidiasis is a significant cause of morbidity and mortality in immunosuppressed individuals. Currently, there are limited treatment options for this opportunistic infection and there have been many reports in the literature of increased resistance to treatment. There is evidence to suggest that phenotypic switching of Candida albicans may play a role in this resistance. It was therefore, the purpose of this study to assess the variability among C. albicans switch phenotypes isolated from a single strain.
Material/Methods:Four switch phenotypes from a single strain of Candida albicans isolated from an HIV+ individual were evaluated for growth rates, post-antifungal effects in the presence of fluconazole, fluconazole uptake and morphological changes after fluconazole exposure.
Results:We found that, overall, smooth white and very wrinkled grew significantly faster then either ring or heavily myceliated and were most drastically affected by 4X and 6X MIC concentrations of fluconazole over a 24 hour period. When all four phenotypes were exposed to 64.
Conclusions:These results suggest that switch phenotypes from Candida albicans serve different roles in providing adaptability and survivability under differing conditions.
Keywords: Antifungal Agents - pharmacology, Blotting, Southern, Candida albicans - drug effects, Candida albicans - genetics, Candida albicans - growth & development, Candida albicans - physiology, Candidiasis - drug therapy, Candidiasis - metabolism, Candidiasis - microbiology, Drug Resistance, Fungal - drug effects, Drug Resistance, Fungal - genetics, Fluconazole - metabolism, Fluconazole - pharmacology, HIV Infections - microbiology, Phenotype, Time Factors, Tritium, Antifungal Agents - pharmacology, Blotting, Southern, Candida albicans - physiology, Candidiasis - microbiology, Drug Resistance, Fungal - genetics, Fluconazole - pharmacology, HIV Infections - microbiology, Phenotype, Time Factors, Tritium
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952